DBDavid Bakalov

David Bakalov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David Bakalov has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Anastassia Amaro

    Penn Metabolic Medicine, Division of Endocrinology, University of Pennsylvania, Philadelphia, USA

    1 shared publication
  • Andrew Chang

    Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

    1 shared publication
  • Bijan Pesaran

    Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

    1 shared publication
  • Casey Harrison Halpern

    University of Pennsylvania

    1 shared publication
  • Daniel Batista

    Department of Psychiatry and Biobehavioral Sciences, Jane and Terry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, USA

    1 shared publication
  • Disha Joshi

    Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

    1 shared publication

Latest Publications

  • Open Access

    Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide

    by Wonkyung Choi, Young-Hoon Nho, Liming Qiu, Andrew Chang, Gustavo Campos, Robert L. Seilheimer, W. Bryan Wilent, David Bakalov, Nida Firdous, Marie Kerr, et al.

    Obesity and related conditions are associated with distressing food preoccupation that often culminates in dysregulated eating behaviors. Incretin-based therapies can reduce excessive weight in obesity, but their impact on dysregulated eating behaviors remains largely unexamined. Understanding how these pharmacologics engage the brain’s mesolimbic circuitry may inform the expansion of their therapeutic potential. We report a rare, first-in-human exploration of the physiological action of these therapies by examining the electrophysiology directly within the human nucleus accumbens. After a short-term course of tirzepatide, the patient-participant exhibited increased severe food preoccupation episodes, which were preceded by an increased delta–theta frequency (≤7 Hz) power in the nucleus accumbens region. We propose that the effects of an incretin-based therapy (tirzepatide) on food preoccupation may be associated with modulation of aberrant activity within this key hub of human mesolimbic circuitry.